Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses | Zendy

Brendan T. Freitas | Zendy; Daniil A. Ahiadorme | Zendy; Rahul S. Bagul | Zendy; Ian A. Durie | Zendy; Samir Ghosh | Zendy; Jarvis Hill | Zendy; Naomi E. Kramer | Zendy; Jackelyn Murray | Zendy; Brady O’Boyle | Zendy; Emmanuel Onobun | Zendy; Michael G. Pirrone | Zendy; Justin D. Shepard | Zendy; Suzanne Enos | Zendy; Yagya Prasad Subedi | Zendy; Kapil Upadhyaya | Zendy; Ralph A. Tripp | Zendy; Brian S. Cummings | Zendy; David Crich | Zendy; Scott D. Pegan | Zendy

Open Access

Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses

Author(s) -

Brendan T. Freitas,

Daniil A. Ahiadorme,

Rahul S. Bagul,

Ian A. Durie,

Samir Ghosh,

Jarvis Hill,

Naomi E. Kramer,

Jackelyn Murray,

Brady O’Boyle,

Emmanuel Onobun,

Michael G. Pirrone,

Justin D. Shepard,

Suzanne Enos,

Yagya Prasad Subedi,

Kapil Upadhyaya,

Ralph A. Tripp,

Brian S. Cummings,

David Crich,

Scott D. Pegan

Publication year - 2022

Publication title -

acs infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.324

H-Index - 39

ISSN - 2373-8227

DOI - 10.1021/acsinfecdis.1c00631

Subject(s) - coronavirus , proteases , isg15 , biology , virology , protease , enzyme , ubiquitin , covid-19 , medicine , disease , genetics , biochemistry , gene , infectious disease (medical specialty) , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research